These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 7923329
1. [Lymphocyte subpopulations determined by flow cytometry in chronic type B lymphatic leukemia]. Kvasnicka J, Kruzík P, Cmunt E, Neurwirtová R. Cas Lek Cesk; 1994 Aug 22; 133(16):506-10. PubMed ID: 7923329 [Abstract] [Full Text] [Related]
2. B cells CD19+ in patients with B-cell chronic lymphocytic leukaemia and autoimmune haemolytic anaemia. Słomkowski M, Kopeć-Szlezak J, Fabijańska-Mitek J, Podstawka U, Sikorska A, Mendek-Czajkowska E. Clin Lab Haematol; 2004 Dec 22; 26(6):385-9. PubMed ID: 15595995 [Abstract] [Full Text] [Related]
3. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment. Kusenda J, Babusíková O. Neoplasma; 2004 Dec 22; 51(2):97-102. PubMed ID: 15190418 [Abstract] [Full Text] [Related]
4. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia. Wolowiec D, Ciszak L, Kosmaczewska A, Bocko D, Teodorowska R, Frydecka I, Kuliczkowski K. Haematologica; 2001 Dec 22; 86(12):1296-304. PubMed ID: 11726322 [Abstract] [Full Text] [Related]
7. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia]. Diop S, Letestu R, Orsolani D, Leboeuf Y, Le Tutour P, Thiam D, Diakhate L, Valensi F. Dakar Med; 2005 Dec 22; 50(2):65-8. PubMed ID: 16295759 [Abstract] [Full Text] [Related]
8. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases. Klabusay M, Sukova V, Coupek P, Brychtova Y, Mayer J. Cytometry B Clin Cytom; 2007 Sep 22; 72(5):363-70. PubMed ID: 17428002 [Abstract] [Full Text] [Related]
9. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia. Bojarska-Junak A, Rolinski J, Wasik-Szczepaneko E, Kaluzny Z, Dmoszynska A. Haematologica; 2002 May 22; 87(5):490-9. PubMed ID: 12010662 [Abstract] [Full Text] [Related]
10. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders. Cabezudo E, Carrara P, Morilla R, Matutes E. Haematologica; 1999 May 22; 84(5):413-8. PubMed ID: 10329919 [Abstract] [Full Text] [Related]
11. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination. Rutella S, Rumi C, Puggioni P, Barberi T, Di Mario A, Larocca LM, Leone G. Haematologica; 1999 May 22; 84(5):419-24. PubMed ID: 10329920 [Abstract] [Full Text] [Related]
18. Clinical utility of flow cytometry in the chronic lymphoid leukemias. DiGiuseppe JA, Borowitz MJ. Semin Oncol; 1998 Feb 22; 25(1):6-10. PubMed ID: 9482521 [Abstract] [Full Text] [Related]
19. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RI. Cancer Res; 2001 Jun 01; 61(11):4483-9. PubMed ID: 11389079 [Abstract] [Full Text] [Related]
20. Reactivity of monoclonal antibodies OK-CLL (anti-CD5) with peripheral blood cells of patients with B cell lymphoproliferative disorders. Milosević D, Marinković M, Jelić S, Colović M, Spuzić I. Arch Immunol Ther Exp (Warsz); 1995 Jun 01; 43(1):23-9. PubMed ID: 8744680 [Abstract] [Full Text] [Related] Page: [Next] [New Search]